54
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Impact of mobile health and medical applications on clinical practice in gastroenterology

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mobile health apps (MHAs) and medical apps (MAs) are becoming increasingly popular as digital interventions in a wide range of health-related applications in almost all sectors of healthcare. The surge in demand for digital medical solutions has been accelerated by the need for new diagnostic and therapeutic methods in the current coronavirus disease 2019 pandemic. This also applies to clinical practice in gastroenterology, which has, in many respects, undergone a recent digital transformation with numerous consequences that will impact patients and health care professionals in the near future. MHAs and MAs are considered to have great potential, especially for chronic diseases, as they can support the self-management of patients in many ways. Despite the great potential associated with the application of MHAs and MAs in gastroenterology and health care in general, there are numerous challenges to be met in the future, including both the ethical and legal aspects of applying this technology. The aim of this article is to provide an overview of the current status of MHA and MA use in the field of gastroenterology, describe the future perspectives in this field and point out some of the challenges that need to be addressed.

          Related collections

          Most cited references93

          • Record: found
          • Abstract: found
          • Article: not found

          Digital technology and COVID-19

          The past decade has allowed the development of a multitude of digital tools. Now they can be used to remediate the COVID-19 outbreak.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

            Summary The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Digital health: a path to validation

              Digital health solutions continue to grow in both number and capabilities. Despite these advances, the confidence of the various stakeholders — from patients and clinicians to payers, industry and regulators — in medicine remains quite low. As a result, there is a need for objective, transparent, and standards-based evaluation of digital health products that can bring greater clarity to the digital health marketplace. We believe an approach that is guided by end-user requirements and formal assessment across technical, clinical, usability, and cost domains is one possible solution. For digital health solutions to have greater impact, quality and value must be easier to distinguish. To that end, we review the existing landscape and gaps, highlight the evolving responses and approaches, and detail one pragmatic framework that addresses the current limitations in the marketplace with a path toward implementation.
                Bookmark

                Author and article information

                Contributors
                Journal
                World J Gastroenterol
                World J. Gastroenterol
                WJG
                World Journal of Gastroenterology
                Baishideng Publishing Group Inc
                1007-9327
                2219-2840
                7 August 2020
                7 August 2020
                : 26
                : 29
                : 4182-4197
                Affiliations
                Didactics and Educational Research in Health Science, Faculty of Health, Witten/Herdecke University, Witten 58455, Germany
                Didactics and Educational Research in Health Science, Faculty of Health, Witten/Herdecke University, Witten 58455, Germany
                Department of GI-, Thoracic- and Vascular Surgery, Dresden Technical University, University Hospital Dresden, Dresden 01307, Germany
                Department of GI-, Thoracic- and Vascular Surgery, Dresden Technical University, University Hospital Dresden, Dresden 01307, Germany
                Didactics and Educational Research in Health Science, Faculty of Health, Witten/Herdecke University, Witten 58455, Germany
                Department of GI-, Thoracic- and Vascular Surgery, Dresden Technical University, University Hospital Dresden, Dresden 01307, Germany. ulrich.bork@ 123456uniklinikum-dresden.de
                Author notes

                Author contributions: Kernebeck S and Bork U did the conception and the design of the manuscript; Kernebeck S wrote the original draft; Busse TS was involved in the writing review and editing of the manuscript; Kernebeck S, Busse TS, Bork U, Ehlers J, Weitz J and Boettcher MD made critical revisions of the manuscript; All authors approved the final version of the article to be published.

                Corresponding author: Ulrich Bork, MD, Attending Doctor, Department of GI-, Thoracic- and Vascular Surgery, University of Dresden, Fetscherstr. 74, Dresden 01307, Germany. ulrich.bork@ 123456uniklinikum-dresden.de

                Article
                jWJG.v26.i29.pg4182
                10.3748/wjg.v26.i29.4182
                7422538
                32848328
                09dd768e-704b-4dad-b5e4-212327617838
                ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

                This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.

                History
                : 31 March 2020
                : 9 June 2020
                : 23 July 2020
                Categories
                Review

                mobile health,health applications,medical applications,technology,telemedicine,mobile applications,smartphone,ehealth,mhealth,digital biomarker,electronic health records

                Comments

                Comment on this article